Now Available! Access the latest issue of Transplantation and Cellular Therapy
Read the Journal
Access the latest news, session previews, and speaker spotlights from the 2025 Tandem Meetings.
Read More
Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Become a Member
ASTCT Talks features industry leaders coming together to tackle important subjects in the growing field of transplantation and cellular therapy. You can listen to ASTCT Talks on the following platforms: Spotify, Google Podcasts and Apple Podcasts.
Listen Here
Researchers believe that engineering chimeric antigen receptor (CAR) T cells to recognize CD155 is a novel approach that could be appropriate for both hematologic and solid tumors.
Fludarabine is valued for its role in chimeric antigen receptor (CAR) T-cell therapy, but scientists believe moving away from fixed dosages could mediate better outcomes.
View More
Check Out the Guideline
Join ASTCT Director of Government Relations, Molly Ford, and Reimbursement and Policy Advisors from Nimitt Consulting for a webinar on Medicare rule updates.
Over the past six decades, Brasília has grown and developed, becoming a vibrant city at the heart of our country. During this period, we have also witnessed the immense advancement of Bone Marrow Transplantation (BMT) and Cell Therapy worldwide, which have established themselves as powerful tools in the treatment of serious and potentially fatal diseases, saving thousands of lives every year.
This webinar will feature a panel to discuss what the FACT accreditation process looks like in a community provider setting.
More Meetings
Browse all Education